Fiscal Year Ending March 2026 Q3 Financial Summary [IFRS] (Consolidated)

Summary of Results

For the consolidated cumulative third quarter period of the fiscal year ending March 2026, net sales were 1,164.1 billion yen (1.1% YoY increase) and operating income was 145.9 billion yen (5.6% YoY increase). This increase was mainly due to higher sales in the Seasonings and Foods segment, with the Healthcare and other segments also showing increased profit. Net income attributable to owners of parent for the quarter rose to 89.7 billion yen (8.9% YoY increase). The full-year earnings guidance has been revised to net sales of 1,600.0 billion yen (4.5% YoY increase), operating income of 181.0 billion yen (13.6% YoY increase), and net income attributable to owners of parent of 130.0 billion yen (85.0% YoY increase).

Segment Performance and Financial Position

The Seasonings & Foods segment posted net sales of 695.0 billion yen (102.5% YoY) and operating income of 113.5 billion yen (102.2% YoY), achieving both sales and profit growth. The Frozen Foods segment reported net sales of 216.7 billion yen (99.1% YoY) and operating income of 8.4 billion yen (76.7% YoY), experiencing decreases in both sales and profit. The Healthcare and other segments recorded net sales of 242.5 billion yen (99.9% YoY) and operating income of 48.8 billion yen (126.2% YoY), with profit growth. Total assets stood at 1,897.3 billion yen, total equity was 819.3 billion yen, and the equity ratio attributable to owners of parent was 39.2%. Cash flow included inflow of 164.3 billion yen from operating activities, outflow of 79.8 billion yen from investing activities, and outflow of 57.1 billion yen from financing activities. Cash and cash equivalents at the end of the period were 201.8 billion yen.